The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.
In humans, Streptococcus pneumoniae (SPN) is the leading cause of bacterial meningitis, a disease with high attributable mortality and frequent permanent neurological sequelae. The molecular mechanisms underlying the central nervous system tropism of SPN are incompletely understood, but include a primary interaction of the pathogen with the blood-brain barrier (BBB) endothelium. All SPN strains possess a gene encoding the surface-anchored sialidase (neuraminidase) NanA, which cleaves sialic acid on host cells and proteins. Here, we use an isogenic SPN NanA-deficient mutant and heterologous expression of the protein to show that NanA is both necessary and sufficient to promote SPN adherence to and invasion of human brain microvascular endothelial cells (hBMECs). NanA-mediated hBMEC invasion depends only partially on sialidase activity, whereas the N-terminal lectinlike domain of the protein plays a critical role. NanA promotes SPN-BBB interaction in a murine infection model, identifying the protein as proximal mediator of CNS entry by the pathogen.
Uchiyama
Satoshi
S
Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
Carlin
Aaron F
AF
Khosravi
Arya
A
Weiman
Shannon
S
Banerjee
Anirban
A
Quach
Darin
D
Hightower
George
G
Mitchell
Tim J
TJ
Doran
Kelly S
KS
Nizet
Victor
V
D000818:Animals; D001812:Blood-Brain Barrier / Q000382:microbiology*; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology; D017931:DNA Primers / Q000235:genetics; D042783:Endothelial Cells / Q000378:metabolism*; D006801:Humans; D008297:Male; D016920:Meningitis, Bacterial / Q000235:genetics / Q000378:metabolism* / Q000382:microbiology; D051379:Mice; D008807:Mice, Inbred BALB C; D019158:N-Acetylneuraminic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D009439:Neuraminidase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D010957:Plasmids / Q000235:genetics; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000378:metabolism*
D017931:DNA Primers; C036137:2-deoxy-2,3-dehydro-N-acetylneuraminic acid; D009439:Neuraminidase; D019158:N-Acetylneuraminic Acid
Structure. 1994 Jun 15;2(6):535-44
7922030
J Clin Invest. 1971 May;50(5):979-85
4396434
Enzyme. 1989;41(3):143-50
2542012
Infect Immun. 2002 Nov;70(11):6504-8
12379738
J Exp Med. 1999 Dec 20;190(12):1825-36
10601357
J Clin Invest. 2002 Jan;109(1):19-27
11781347
Infect Immun. 1994 Sep;62(9):3688-95
8063384
Lancet Infect Dis. 2002 Dec;2(12):721-36
12467688
FEMS Microbiol Rev. 1996 Jul;18(4):289-99
8703507
J Exp Med. 1944 Feb 1;79(2):137-58
19871359
Infect Immun. 1997 Nov;65(11):4411-8
9353013
Infect Immun. 2006 Jul;74(7):4014-20
16790774
Infect Immun. 2006 Jun;74(6):3360-5
16714565
Acta Otolaryngol. 2002 Jun;122(4):413-9
12125999
Mol Cell. 2002 Oct;10(4):757-68
12419220
J Neurochem. 2004 Oct;91(2):385-94
15447671
Int Immunol. 2002 Mar;14(3):299-308
11867566
Lancet Neurol. 2006 Feb;5(2):123-9
16426988
Int J Parasitol. 2006 May 1;36(5):607-14
16542662
J Infect Dis. 2004 Nov 1;190(9):1661-9
15478073
Infect Immun. 1997 Dec;65(12):5074-81
9393798
Infect Immun. 1995 Nov;63(11):4470-5
7591087
Infect Immun. 2005 Nov;73(11):7775-8
16239584
J Clin Invest. 2009 Jun;119(6):1638-46
19436113
N Engl J Med. 2004 Oct 28;351(18):1849-59
15509818
J Clin Invest. 1998 Jul 15;102(2):347-60
9664076
Microb Pathog. 1988 Jan;4(1):33-43
3143891
Mol Microbiol. 2006 Feb;59(3):961-74
16420364
Glycoconj J. 1993 Feb;10(1):40-4
8358225
J Bacteriol. 2007 Jan;189(1):38-51
17041037
Res Microbiol. 2006 Jul-Aug;157(6):569-74
16844348
Nat Rev Neurosci. 2003 May;4(5):376-85
12728265
Infect Immun. 2002 Dec;70(12):7161-4
12438402
Infect Immun. 2005 May;73(5):2680-9
15845469
J Clin Invest. 2005 Sep;115(9):2499-507
16138192
J Neuroimmunol. 2007 Mar;184(1-2):45-52
17210186
Mol Biol Cell. 2000 Apr;11(4):1487-98
10749944